Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Total Non-Current Liabilities (2022 - 2025)

Lucid Diagnostics' Total Non-Current Liabilities history spans 3 years, with the latest figure at $5.5 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 18.07% year-over-year to $5.5 million; the TTM value through Dec 2025 reached $5.5 million, down 18.07%, while the annual FY2025 figure was $5.5 million, 18.07% down from the prior year.
  • Total Non-Current Liabilities reached $5.5 million in Q4 2025 per LUCD's latest filing, down from $6.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $6.7 million in Q4 2024 to a low of $1.3 million in Q2 2022.
  • Average Total Non-Current Liabilities over 3 years is $3.7 million, with a median of $3.5 million recorded in 2022.
  • The largest YoY upside for Total Non-Current Liabilities was 18.07% in 2025 against a maximum downside of 18.07% in 2025.
  • A 3-year view of Total Non-Current Liabilities shows it stood at $1.3 million in 2022, then surged by 424.49% to $6.7 million in 2024, then decreased by 18.07% to $5.5 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Total Non-Current Liabilities are $5.5 million (Q4 2025), $6.7 million (Q4 2024), and $1.3 million (Q2 2022).